Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Biosensors
GrapheneDx, General Graphene, Sapphiros partner to develop graphene IVD biosensors
GrapheneDx's first tests to be released under the collaboration will be for the diagnosis of sexually transmitted infections, including chlamydia and gonorrhea, using a urine sample.
June 7, 2023
Fast, cheap method for detecting antimicrobial resistance could improve infectious disease care
Researchers at Ecole Polytechnique Fédérale de Lausanne in Switzerland have described a method for quickly determining if a pathogen is sensitive to an antibiotic using basic equipment.
April 25, 2023
Northwestern University researchers developing biosensor that amplifies molecular signals in the body
Molecules in the body send faint biochemical signals when health issues arise. Researchers are working on a biosensor that boosts these signals, and they believe the method could facilitate real-time diagnostic testing.
April 4, 2023
Prediabetes self-screening via smartphone
If commercialized, a new system could enable people to self-screen for prediabetes on their smartphones, using modified commercially available test strips.
April 3, 2023
Amplified Sciences developing dye-based tests for early detection of pancreatic cancer
Tests under development by the Purdue Research Foundation-affiliated startup use dyes to identify the potential for malignancy in fluid extracted from a cyst on the pancreas.
March 15, 2023
Prototype sweat sensor developed to detect medical conditions
Human sweat comes in different forms which contain biomarkers that could assist doctors in making health diagnoses.
February 27, 2023
Probe measures cell stiffness and traction
Seeking ways to alter the probe's mechanical characteristics after injecting it into a tissue of interest, the researchers settled on hydrogels made of polyethylene glycol, a material approved for human use.
January 25, 2023
Saliva-based graphene sensor shows high sensitivity in preliminary studies
IdentifySensors Biologics is developing saliva-based digital graphene nanosensor technology that it believes can be more sensitive than PCR in detecting COVID-19.
December 12, 2022
Measuring fitness, disease risk without strenuous testing in the lab
University of Cambridge researchers used a deep neural network to process and extract information from raw sensor data and to predict VO2max, an indicator of fitness and marker of heart disease and mortality risk.
December 1, 2022
Chest publication suggests potential for MagArray blood test to stratify lung cancer risk
Its Knodule ID test is a multianalyte assay with algorithmic analysis comprising seven protein biomarkers and six clinical factors.
November 21, 2022
Glympse to present data on the detection of hepatocellular carcinoma with biosensor platform
In combination, the Glympse assay and a blood biomarker test demonstrated an area under the curve (AUC) of 0.90 in differentiating HCC and cirrhosis patients.
October 25, 2022
ProtonDx secures £365K grant to develop point-of-care tests for porcine lung disease
ProtonDx said this week it has been awarded a £365,000 ($404,238 U.S.) grant from two organizations to develop point-of-care tests for porcine lung diseases.
September 29, 2022
Page 1 of 3
Next Page
